EOG
56
4
CMCSA
32
-2
VMC
44
2
RHI
50
2
MA
57
4
DHR
50
3
SPG
43
2
MS
65
-4
PLD
46
5
HAL
53
5
CINF
38
3
ED
52
4
URI
48
3
XEL
51
7
FITB
46
-2
CMS
72
4
SLB
49
3
EXC
69
3
LLY
33
3
BIIB
35
3
EOG
56
4
CMCSA
32
-2
VMC
44
2
RHI
50
2
MA
57
4
DHR
50
3
SPG
43
2
MS
65
-4
PLD
46
5
HAL
53
5
CINF
38
3
ED
52
4
URI
48
3
XEL
51
7
FITB
46
-2
CMS
72
4
SLB
49
3
EXC
69
3
LLY
33
3
BIIB
35
3
Financhill
Back

Neurogene Stock Predictions

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]
Sell
13

NGNE
Neurogene

Last Price:
$16.78
Seasonality Move:
0.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 29.2% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $17.63. The Score for NGNE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 29.2% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
13
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
14.44

Prediction Charts

Market Cap:
261.9M
Price in USD:
17.63
Volume:
149.5K
Beta:
-1.32

Technical Analysis

SMA50:
28.68
SMA100:
35.68
SMA200:
36.19
52-Wk Change:
-45.42%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 17.63 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-26 23.32 24.10 24.84 23.01
Dec-27 24.83 22.97 24.83 22.96
Dec-30 22.19 22.28 22.54 21.29
Dec-31 22.60 22.86 23.37 21.33
Jan-2 23.49 22.89 23.84 22.44
Jan-3 22.91 23.23 23.80 22.64
Jan-6 23.31 23.12 24.00 22.90
Jan-7 22.59 21.86 23.62 21.44
Jan-8 21.63 21.49 22.23 20.65
Jan-10 20.85 19.58 20.85 19.27
Jan-13 19.10 18.81 19.32 17.91
Jan-14 19.07 17.89 20.29 17.63
Jan-15 18.59 18.54 19.14 18.15
Jan-16 18.43 17.63 18.48 17.50

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.